Clinical Study for Skin and Scalp Diseases in Individuals with Down Syndrome
This study is testing whether a medicine called abrocitinib can help people 12 years and older with Down syndrome treat alopecia areata (hairloss) and symptoms of atopic dermatitis (eczema).
Principal investigator
Emma Guttman, MD, PhD and Dusan Bogunovic, PhD
Location
New York, NY
Age range
12 years and older